Choosing antithrombotics for atrial fibrillation in primary care
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the UK affecting 1.3 million people. AF is particularly common in older people, with one in ten over the age of 75 years affected. The prevalence of AF is projected to increase with improved survival of patients from chronic cardiac d...
Үндсэн зохиолчид: | Mustafa, M, Sheppard, JP |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Royal College of General Practictioners
2020
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
-н: E V Schlyakhto, зэрэг
Хэвлэсэн: (2022-01-01) -
Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study
-н: Charis Xuan Xie, зэрэг
Хэвлэсэн: (2022-12-01) -
ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
-н: A. Y. Rychkov, зэрэг
Хэвлэсэн: (2016-01-01) -
Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
-н: V. I. Petrov, зэрэг
Хэвлэсэн: (2019-03-01) -
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
-н: E. A. Ushkalova, зэрэг
Хэвлэсэн: (2017-05-01)